Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT05740995 · RECRUITING
Trial details
- NCT number
- NCT05740995
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.